Market accessOfficial

AIFA publishes sunset clause pre-notice for medicines facing lapse in early 2027

🇮🇹 AIFA · Tue 17 Nov 2026

Italy's medicines agency has issued a warning listing products at potential risk of losing their marketing authorisation for non-marketing, with lapse dates between January and March 2027.

The Italian Medicines Agency (AIFA) published a sunset clause pre-notice on 17 November 2026. It lists medicinal products potentially facing lapse of their marketing authorisation because they have not been marketed.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: AIFA ↗

Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.